Literature DB >> 31529478

New Guidelines: Interpretation, Application and the Future.

Andrew D Hershey1,2, Maryam Oskoui3,4, Tamara Pringsheim5, Yolanda Holler-Managan6, Sonja Potrebic7, Lori Billinghurst8,9,10, David Gloss11, Nicole Licking12, Michael Sowell13, M Cristina Victorio14, Elaine Gersz15, Emily Vrijsen16, Heather Zanitsch17, Marcy Yonker18, Kenneth Mack19, Amy A Gelfand20, Christina L Szperka8,9,10, Scott W Powers1,2.   

Abstract

Year:  2019        PMID： 31529478     DOI： 10.1111/head.13629

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  1 in total

1.  Prevalence of Headache Days and Disability 3 Years After Participation in the Childhood and Adolescent Migraine Prevention Medication Trial.

Authors:  Scott W Powers; Christopher S Coffey; Leigh A Chamberlin; Dixie J Ecklund; Elizabeth A Klingner; Jon W Yankey; James L Peugh; Leslie L Korbee; Kerry Simmons; Stephanie M Sullivan; Marielle A Kabbouche; Joanne Kacperski; Linda L Porter; Brooke L Reidy; Andrew D Hershey
Journal:  JAMA Netw Open       Date:  2021-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.